Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Rheumatology|December 21, 2019
Association between autoantibody level and disease activity in rheumatoid arthritis is dependent on baseline inflammationGeorg Pongratz, Ruth Frieser, Ralph Brinks, et al.
Plos One|May 30, 2019
Introduction and validation of a new semi-automated method to determine sympathetic fiber density in target tissuesDennis Bleck, Li Ma, Lkham Erdene-Bymbadoo, et al.
Skeletal Radiology|August 27, 2020
Differentiating rheumatoid and psoriatic arthritis: a systematic analysis of high-resolution magnetic resonance imaging features-preliminary findingsDaniel B Abrar, Christoph Schleich, Ralph Brinks, et al.
BMJ Open Diabetes Research & Care|February 14, 2018
All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in GermanySusanne Röckl, Ralph Brinks, Jens Baumert, et al.
The Journal of Rheumatology|September 18, 2012
Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational studyRebecca Fischer-Betz, Gamal Chehab, Oliver Sander, et al.
Rheumatology (Oxford, England)|May 15, 2018
Vaccination coverage in systemic lupus erythematosus-a cross-sectional analysis of the German long-term study (LuLa cohort)Gamal Chehab, Jutta G Richter, Ralph Brinks, et al.
The International Journal of Prosthodontics|November 14, 2024
Thirty-Year Clinical Performance of Double-Crown Retained Removable Partial Dentures - A Practice-Based Retrospective StudyLea S Prott, Zara A von Zitzewitz, Ralph Brinks, et al.
BMJ Open Diabetes Research & Care|January 18, 2021
Estimating the impact of tax policy interventions on the projected number and prevalence of adults with type 2 diabetes in Germany between 2020 and 2040Thaddäus Tönnies, Christin Heidemann, Rebecca Paprott, et al.
Patient Preference and Adherence|December 7, 2019
Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous InjectionsJohanna Mucke, Ralph Brinks, Rebecca Fischer-Betz, et al.
GMS Hygiene and Infection Control|December 24, 2025
In-hospital mortality from healthcare-associated infection by multidrug-resistant Pseudomonas aeruginosa: a competing risks analysis of a 4-year propensity-matched cohort study in southern ChinaMouqing Zhou, Evangelos I Kritsotakis, Baohua Xu, et al.
Pageof 12